Treatment of angiokeratomas of Fordyce with topical rapamycin 0.25% cream

por Bell, Katheryn A., Guo, Emily L., DeKlotz, Cynthia M.C.
Publicado en JAAD Case Rep (2020)

Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia

por Lim, Young H., Ovejero, Diana, Sugarman, Jeffrey S., DeKlotz, Cynthia M.C., Maruri, Ann, Eichenfield, Lawrence F., Kelley, Patrick K., Jüppner, Harald, Gottschalk, Michael, Tifft, Cynthia J., Gafni, Rachel I., Boyce, Alison M., Cowen, Edward W., Bhattacharyya, Nisan, Guthrie, Lori C., Gahl, William A., Golas, Gretchen, Loring, Erin C., Overton, John D., Mane, Shrikant M., Lifton, Richard P., Levy, Moise L., Collins, Michael T., Choate, Keith A.
Publicado 2014